Webinar | January 2, 2019

CCI Testing And Revisions To EU Annex 1

The draft of the revised EU Annex 1, on manufacturing of sterile medicinal products, was recently released. At a first glance the changes might seem subtle, however the new language will likely have a significant impact on your CCI testing practices. Regulators are paying closer attention to the proper design of robust CCI studies, validation of CCI testing methods and the generation of statistical data. In this webinar we will go over CCI testing strategies and the proposed revisions to EU Annex 1.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online